Login / Signup

Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol.

Chunhoo CheonSeong-Gyu Ko
Published in: Medicine (2020)
ClinicalTrials.gov NCT04360317.
Keyphrases
  • study protocol
  • randomized controlled trial
  • papillary thyroid
  • clinical trial
  • squamous cell
  • open label
  • young adults